➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Baxter
Mallinckrodt
Harvard Business School
Moodys

Last Updated: March 4, 2021

DrugPatentWatch Database Preview

Methylprednisolone sodium succinate - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for methylprednisolone sodium succinate and what is the scope of freedom to operate?

Methylprednisolone sodium succinate is the generic ingredient in four branded drugs marketed by Abbott, Hospira, Hospira Inc, Elkins Sinn, Organon Usa Inc, Abraxis Pharm, Amneal, Aurobindo Pharma Ltd, Bedford Labs, Fresenius Kabi Usa, Hikma, Intl Medication, Sagent Pharms Inc, Teva Parenteral, Watson Labs, and Pharmacia And Upjohn, and is included in forty-seven NDAs. Additional information is available in the individual branded drug profile pages.

There are forty drug master file entries for methylprednisolone sodium succinate. Twelve suppliers are listed for this compound.

Summary for methylprednisolone sodium succinate
Recent Clinical Trials for methylprednisolone sodium succinate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Tel-Aviv Sourasky Medical CenterN/A
Hospital Sao DomingosPhase 2
Fundação de Medicina Tropical Dr. Heitor Vieira DouradoPhase 2

See all methylprednisolone sodium succinate clinical trials

Pharmacology for methylprednisolone sodium succinate

US Patents and Regulatory Information for methylprednisolone sodium succinate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira A-METHAPRED methylprednisolone sodium succinate INJECTABLE;INJECTION 089174-001 Aug 18, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
Sagent Pharms Inc METHYLPREDNISOLONE SODIUM SUCCINATE methylprednisolone sodium succinate INJECTABLE;INJECTION 040888-001 Jul 18, 2011 AP RX No No   Start Trial   Start Trial   Start Trial
Bedford Labs METHYLPREDNISOLONE SODIUM SUCCINATE methylprednisolone sodium succinate INJECTABLE;INJECTION 040709-002 Feb 21, 2007 DISCN No No   Start Trial   Start Trial   Start Trial
Abraxis Pharm METHYLPREDNISOLONE SODIUM SUCCINATE methylprednisolone sodium succinate INJECTABLE;INJECTION 088676-001 Jun 8, 1984 DISCN No No   Start Trial   Start Trial   Start Trial
Hospira A-METHAPRED methylprednisolone sodium succinate INJECTABLE;INJECTION 089173-001 Aug 18, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
Express Scripts
Merck
Baxter
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.